Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease.

Antimicrobial Agents and Chemotherapy
K A Nash, C B Inderlied

Abstract

Clarithromycin (CLM) and azithromycin (AZM) are important agents in the treatment of disseminated Mycobacterium avium complex disease; however, monotherapy with these macrolides often leads to clinically significant resistance. The underlying resistance mechanism was investigated by comparing 23S rRNA gene sequences in the domain V region of 10 CLM-susceptible strains included in this study. The only differences in the domain V sequences associated with CLM resistance were at position 2274 of the complete M. avium 23S rRNA gene (GenBank accession no. X74494). All the CLM-susceptible strains had an A residue at this site, whereas seven of the eight CLM-resistant strains had either a C, G, or T. Four of these seven CLM-resistant strains emerged during monotherapy with CLM and two emerged during AZM monotherapy, showing that resistance selected by either macrolide was associated with mutation of the 23S rRNA gene. Thermodynamic analysis of secondary rRNA structure suggests that the observed mutations cause an alteration in free energy associated with rRNA folding, which may result in a localized conformation change in assembled ribosomes. Such a shift may be important in the resistance of ribosomes to the effects of macrolides. Th...Continue Reading

References

Jan 1, 1990·Methods in Enzymology·J A JaegerM Zuker
Jan 1, 1988·Microbiology and Immunology·Y Suzuki, T Yamada
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J A JaegerM Zuker
May 14, 1986·Biochemical and Biophysical Research Communications·H BercovierS Sela
Feb 1, 1987·Journal of Bacteriology·Y SuzukiT Yamada
Jan 1, 1988·Methods in Enzymology·C D SigmundE A Morgan
Jun 11, 1984·Nucleic Acids Research·C D SigmundE A Morgan
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·B Weisblum
Jun 1, 1994·The Journal of Antimicrobial Chemotherapy·K ColemanI Chopra
Nov 1, 1993·Antimicrobial Agents and Chemotherapy·L HeifetsJ Vanderkolk
May 1, 1994·American Journal of Respiratory and Critical Care Medicine·R J WallaceG H Mazurek
Feb 1, 1994·Antimicrobial Agents and Chemotherapy·A MeierE C Böttger
Nov 1, 1993·Antimicrobial Agents and Chemotherapy·S P KlemensM H Cynamon

❮ Previous
Next ❯

Citations

Aug 15, 1996·FEMS Microbiology Letters·Y J Debets-OssenkoppC M Vandenbroucke-Grauls
Jul 5, 2003·Journal of Microbiological Methods·Mekonnen KurabachewBjarne Bjorvatn
Mar 30, 2005·Proceedings of the National Academy of Sciences of the United States of America·Peter PfisterErik C Böttger
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G L Woods
Dec 14, 2004·The Journal of Antimicrobial Chemotherapy·Kevin A NashRichard J Wallace
Mar 12, 2011·The Journal of Antimicrobial Chemotherapy·Takayuki InagakiKenji Ogawa
Oct 4, 2011·The Journal of Antimicrobial Chemotherapy·Katja LuckeErik C Böttger
Feb 1, 2012·The Journal of Antimicrobial Chemotherapy·Rachid NessarBrigitte Gicquel
Jun 20, 2000·Antimicrobial Agents and Chemotherapy·J L Martinez, F Baquero
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·B Vester, S Douthwaite
May 17, 2001·Antimicrobial Agents and Chemotherapy·K A Nash
Jun 16, 2001·Antimicrobial Agents and Chemotherapy·A E RosatoK A Nash
Jun 16, 2001·Antimicrobial Agents and Chemotherapy·A M NiliusR K Flamm
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·Marja PihlajamäkiJari Jalava
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Karolína BuriánkováJean-Luc Pernodet
Aug 26, 2004·Antimicrobial Agents and Chemotherapy·Paul F RiskaMargaret R Hammerschlag
Jul 6, 2012·Clinical Microbiology Reviews·Barbara A Brown-ElliottRichard J Wallace
May 10, 2013·Journal of Clinical Microbiology·Sara ChristiansonMeenu K Sharma
Jul 22, 2006·American Journal of Respiratory and Critical Care Medicine·David E GriffithRichard J Wallace
Feb 18, 2016·Emerging Infectious Diseases·Ravikiran M RajuEric J Rubin
Apr 29, 2015·Infectious Diseases·Sheng BiJi-Fang Sheng
Apr 25, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jakko van IngenJohan W Mouton
Sep 11, 2009·International Journal of Antimicrobial Agents·Liliana RodriguesMiguel Viveiros
Jan 22, 2011·Journal of Clinical Laboratory Analysis·Seung Heon LeeHee Jin Kim
Jun 17, 2014·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Wenjuan NieNaihui Chu
Jan 15, 2014·Annals of Laboratory Medicine·Seung Heon LeeHee Jin Kim
Jul 5, 2018·Revista Do Instituto De Medicina Tropical De São Paulo·Júlia Silveira ViannaPedro Eduardo Almeida da Silva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
C B Inderlied
Diagnostic Microbiology and Infectious Disease
W J BurmanErik C Böttger
© 2021 Meta ULC. All rights reserved